Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect
The ανβ3 integrin antagonistic ligands, i.e., drugs as nano-architectural design-based nanomedicine, especially for cancer chemotherapy, are discussed.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2021-12-01
|
| Series: | Nanotechnology Reviews |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/ntrev-2022-0020 |
| _version_ | 1811202963893387264 |
|---|---|
| author | Abbas Nahid Yusuf Mohammad Akhtar Naseem Khan Riaz A. |
| author_facet | Abbas Nahid Yusuf Mohammad Akhtar Naseem Khan Riaz A. |
| author_sort | Abbas Nahid |
| collection | DOAJ |
| description | The ανβ3 integrin antagonistic ligands, i.e., drugs as nano-architectural design-based nanomedicine, especially for cancer chemotherapy, are discussed. |
| first_indexed | 2024-04-12T02:46:32Z |
| format | Article |
| id | doaj.art-b20609f93aed49fba189d59db5a0f705 |
| institution | Directory Open Access Journal |
| issn | 2191-9097 |
| language | English |
| last_indexed | 2024-04-12T02:46:32Z |
| publishDate | 2021-12-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Nanotechnology Reviews |
| spelling | doaj.art-b20609f93aed49fba189d59db5a0f7052022-12-22T03:51:08ZengDe GruyterNanotechnology Reviews2191-90972021-12-0111120421910.1515/ntrev-2022-0020Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospectAbbas Nahid0Yusuf Mohammad1Akhtar Naseem2Khan Riaz A.3Acharya and BM Reddy College of Pharmacy, Bengaluru, 560 107, IndiaDepartment of Clinical Pharmacy, Taif University, Taif Al-Haweiah, Taif 21974, Saudi ArabiaDepartment of Pharmaceutics, College of Dentistry and Pharmacy, Buraydah Private Colleges, Buraydah, Qassim 51418, Saudi ArabiaDepartment of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim 51452, Saudi ArabiaThe ανβ3 integrin antagonistic ligands, i.e., drugs as nano-architectural design-based nanomedicine, especially for cancer chemotherapy, are discussed.https://doi.org/10.1515/ntrev-2022-0020integrinsανβ3antagoniststhyrointegrinstherapeuticsnanomedicine |
| spellingShingle | Abbas Nahid Yusuf Mohammad Akhtar Naseem Khan Riaz A. Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect Nanotechnology Reviews integrins ανβ3 antagonists thyrointegrins therapeutics nanomedicine |
| title | Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect |
| title_full | Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect |
| title_fullStr | Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect |
| title_full_unstemmed | Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect |
| title_short | Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect |
| title_sort | contemporary nano architectured drugs and leads for ανβ3 integrin based chemotherapy rationale and retrospect |
| topic | integrins ανβ3 antagonists thyrointegrins therapeutics nanomedicine |
| url | https://doi.org/10.1515/ntrev-2022-0020 |
| work_keys_str_mv | AT abbasnahid contemporarynanoarchitectureddrugsandleadsforanb3integrinbasedchemotherapyrationaleandretrospect AT yusufmohammad contemporarynanoarchitectureddrugsandleadsforanb3integrinbasedchemotherapyrationaleandretrospect AT akhtarnaseem contemporarynanoarchitectureddrugsandleadsforanb3integrinbasedchemotherapyrationaleandretrospect AT khanriaza contemporarynanoarchitectureddrugsandleadsforanb3integrinbasedchemotherapyrationaleandretrospect |